Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access

Experienced Leader in Market Access to Bolster Relief's U.S. Commercial OperationsGENEVA, SWITZERLAND / ACCESSWIRE / August 17, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical company seeking to …